Porocarcinoma; presentation and management, a meta-analysis of 453 cases - PubMed (original) (raw)

Review

doi: 10.1016/j.amsu.2017.06.027. eCollection 2017 Aug.

F H Kakamad 2 3, Hiwa O Baba 4, Rawezh Q Salih 3 5, M R Hawbash 3 6, Shvan H Mohammed 3 5, Snur Othman 4, Yadgar A Saeed 4, Imad J Habibullah 4, Aso S Muhialdeen 4, Rebaz O Nawroly 4, Zuhair D Hammood 4, Nawshirwan H Abdulkarim 4

Affiliations

• PMID: 28721214
• PMCID: PMC5499034
• DOI: 10.1016/j.amsu.2017.06.027

Review

Porocarcinoma; presentation and management, a meta-analysis of 453 cases

Abdulwahid M Salih et al. Ann Med Surg (Lond). 2017.

Abstract

Background: porocarcinoma is a rare sort of skin cancer developing from sweat glands. Its clinical course and management are not well understood.

Objectives: the current meta-analysis is to address the presentation and management of porocarcinoma.

Data sources: Web of Science, PubMed, MEDLINE on OVID and Google scholar were searched for English-language studies published before December 1, 2016.

Results: The review of literature revealed 453 cases. From which 222 (49%) cases were male and female were 231 (51%). The mean age was 67.57 years. The mean duration of presentation was 5.57 years ranging from 4 days to 60 years of age. The most common site of affection is the head and neck (39.9%) followed by lower extremity (33.9%). Mass and nodule are the most common modes of presentation. Metastasis occurred at presentation in 110 (31%) cases. The most common organ to which porocarcinoma metastizes is the nearby lymph node (57.7%).

Conclusions: Porocarcinoma is an aggressive skin cancer. Surgery is the main modality of treatment.

Systematic review registration number: reviewregistry233.

Keywords: Aggressive; Carcinoma; Management; Porocarcinoma; Presentation.

PubMed Disclaimer

Figures

Fig. 1

The process and flow of the literature review.

Similar articles

• A patient with porocarcinoma of the lower extremity and lung metastasis: a rare case report.
  Zein AFMZ, Luthfi M, Putro WA, Nurbaiti N. Zein AFMZ, et al. Med Pharm Rep. 2023 Jul;96(3):318-322. doi: 10.15386/mpr-2387. Epub 2023 Jul 27. Med Pharm Rep. 2023. PMID: 37577018 Free PMC article.
• Porocarcinoma of the Groin: A Case Report.
  Myers HE, Pennycook K, Hammel J. Myers HE, et al. Case Rep Dermatol. 2024 Jun 12;16(1):140-143. doi: 10.1159/000539101. eCollection 2024 Jan-Dec. Case Rep Dermatol. 2024. PMID: 39015401 Free PMC article.
• Eccrine porocarcinoma of the vulva: a case report and review of the literature.
  Fujimine-Sato A, Toyoshima M, Shigeta S, Toki A, Kuno T, Sato I, Watanabe M, Niikura H, Yaegashi N. Fujimine-Sato A, et al. J Med Case Rep. 2016 Nov 10;10(1):319. doi: 10.1186/s13256-016-1106-1. J Med Case Rep. 2016. PMID: 27832810 Free PMC article. Review.
• [Primary eccrine porocarcinoma: a clinicopathological study of 50 cases].
  Skowron F, Poulhalon N, Balme B, Touzet S, Thomas L. Skowron F, et al. Ann Dermatol Venereol. 2014 Apr;141(4):258-64. doi: 10.1016/j.annder.2013.10.047. Epub 2013 Dec 5. Ann Dermatol Venereol. 2014. PMID: 24703639 French.
• Recurrent Metastatic Eccrine Porocarcinoma: A Case Report and Review of the Literature.
  Khaja M, Ashraf U, Mehershahi S, Ayyadurai P, Malik S. Khaja M, et al. Am J Case Rep. 2019 Feb 11;20:179-183. doi: 10.12659/AJCR.913440. Am J Case Rep. 2019. PMID: 30739904 Free PMC article. Review.

Cited by

• Porocarcinoma of the left arm: A report of a rare skin cancer case and literature review.
  Signorelli C, Zanella-Cavallero L, Ranucci V, Pellicciotti A, Ruggeri EM. Signorelli C, et al. Clin Case Rep. 2022 Apr 15;10(4):e05721. doi: 10.1002/ccr3.5721. eCollection 2022 Apr. Clin Case Rep. 2022. PMID: 35441031 Free PMC article.
• Porocarcinoma: Clinical and Histological Features, Immunohistochemistry and Outcomes: A Systematic Review.
  Bienstman T, Güvenç C, Garmyn M. Bienstman T, et al. Int J Mol Sci. 2024 May 25;25(11):5760. doi: 10.3390/ijms25115760. Int J Mol Sci. 2024. PMID: 38891945 Free PMC article. Review.
• Head and Neck Porocarcinoma: SEER Analysis of Epidemiology and Survival.
  Scampa M, Merat R, Kalbermatten DF, Oranges CM. Scampa M, et al. J Clin Med. 2022 Apr 14;11(8):2185. doi: 10.3390/jcm11082185. J Clin Med. 2022. PMID: 35456278 Free PMC article.
• Eccrine Porocarcinoma: A Case Report of a Rare and Aggressive Cutaneous Tumour.
  Oh S, Behzadnia A, Chan J. Oh S, et al. Cureus. 2019 Nov 27;11(11):e6244. doi: 10.7759/cureus.6244. Cureus. 2019. PMID: 31819840 Free PMC article.
• 18F Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Findings in a Case of Metastatic Eccrine Porocarcinoma - An Extremely Rare Malignant Adnexal Tumor.
  Krishna S, Ravina M, Kumar A, Dasgupta S, Kote R. Krishna S, et al. Indian J Nucl Med. 2023 Jan-Mar;38(1):89-90. doi: 10.4103/ijnm.ijnm_140_22. Epub 2023 Feb 24. Indian J Nucl Med. 2023. PMID: 37180188 Free PMC article.

References

1. 1. Devi N.R., Valarmathi K., Lilly M., Satish S., Mishra N. Primary axillary porocarcinoma: a rare cutaneous tumour. J. Clin. Diagn. Res. 2016;10(2):4–6. - PMC - PubMed
2. 1. Luz Murilo de Almedia, Ogata Daniel Cury, Ribeiro Leandro Carvalho. Eccrine porocarcinoma (malignant Eccrine poroma) Clin. (Sao Paulo) 2010;65(7):739–742. - PMC - PubMed
3. 1. Zeidan Youssef H., Jason Zauls A., Sharma Anand K. Treatment of Eccrine porocarcinoma with metastasis to parotid gland. J. Med. Case Rep. 2010;4:147. - PMC - PubMed
4. 1. Fujimura Taku, Hashimoto Akira, Aiba Setsuya. Succesful treatment of eccrine porocarcinoma. Case Rep. Dermatol. 2014;6(2):159–163. - PMC - PubMed
5. 1. Smita Surendra Masamatti, Chowdappa Vijaya. Eccrine porocarcinoma of scalp. J. Clin. Diagn. Res. Ser. online) 2016;1(1):1–16. - PMC - PubMed

Further reading

1. 1. Yamamoto Osamu, Haratake Joji, Yokoyama Shigeo, Imayama Shuhei, Asahi Masakazu. A histopathological and ultrastructural study of eccrine porocarcinoma with special reference to its subtypes. Virchows Arch. A Pathol. Anat. 1992;420:395–401. - PubMed

Publication types

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central

• Other Literature Sources

  • scite Smart Citations